: Eli Lilly Sues Canada On Drug Patents
U.S. pharmaceutical giant Eli Lilly has filed a $500 million international lawsuit against the Canadian government, saying it unfairly shortened the life of patents for its best-selling drugs. The case, filed Thursday under the rules of the North American Free Trade Agreement, threatens to shed a negative light on a dispute resolution mechanism also being proposed by the U.S. as part of the Pacific trade deal (Behsudi, 9/12).
This is part of Kaiser Health News' Daily Report - a summary of health policy coverage from more than 300 news organizations. The full summary of the day's news can be found here and you can sign up for e-mail subscriptions to the Daily Report here. In addition, our staff of reporters and correspondents file original stories each day, which you can find on our home page.